Article
Exploring the Cost-Utility of a Biomarker Predicting Persistent Severe Acute Kidney…
ClinicoEconomics and Outcomes Research · 2024 · Echeverri J, Martins R, Harenski K, Kampf JP, McPherson P, Textoris J, Koyner JL
Key facts
| Title | Exploring the Cost-Utility of a Biomarker Predicting Persistent Severe Acute Kidney Injury: The Case of C-C Motif Chemokine Ligand 14 (CCL14) |
|---|---|
| First author | Echeverri J, Martins R, Harenski K, Kampf JP, McPherson P, Textoris J, Koyner JL |
| Journal | ClinicoEconomics and Outcomes Research |
| Published | Jan 12, 2024 |
| DOI | 10.2147/CEOR.S434971 |
| Devices mentioned | K153165, K171482 |
| Product codes mentioned | PIG |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1